Intellectus Partners, LLC Eli Lilly & CO Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Intellectus Partners, LLC holds 425 shares of LLY stock, worth $338,159. This represents 0.1% of its overall portfolio holdings.

Number of Shares

425

Previous 425 -0.0%

Holding current value

$338,159

Previous $384,000 2.08%

% of portfolio

0.1%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$724.87 - $909.04 $22,470 - $28,180	-31 Reduced 6.8%	425 $384,000
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $3,676 - $4,333	-7 Reduced 1.51%	456 $265,000
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $201,266 - $277,475	463 New	463 $248,000
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $6,752 - $7,868	-21 Reduced 0.98%	2,120 $775,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $9,190 - $10,473	31 Added 1.47%	2,141 $692,000
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $17,838 - $20,945	64 Added 3.13%	2,110 $684,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $4,459 - $5,541	19 Added 0.94%	2,046 $586,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $18,662 - $23,160	83 Added 4.27%	2,027 $559,000
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $348,133 - $428,427	-1,571 Reduced 44.69%	1,944 $449,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $634,633 - $820,893	3,515 New	3,515 $807,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $797,773 - $1.03 Million	-4,855 Closed	0 $0
Q4 2020 Feb 18, 2021	BUY	$130.46 - $172.63 $501,227 - $663,244	3,842 Added 379.27%	4,855 $820,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $371,550 - $491,650	-2,848 Reduced 73.76%	1,013 $820,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $564,555 - $653,010	3,861 New	3,861 $572,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $875,493 - $1.08 Million	-7,354 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $786,289 - $973,890	7,354 New	7,354 $967,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $66,474 - $77,592	-600 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $9,350 - $11,005	-84 Reduced 12.28%	600 $78,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $364,507 - $408,358	-3,442 Reduced 83.42%	684 $79,000
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $17,172 - $21,462	-200 Reduced 4.62%	4,126 $443,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $5,904 - $6,776	78 Added 1.84%	4,326 $369,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $15,584 - $18,396	-210 Reduced 4.71%	4,248 $329,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,458	4,458 $367,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Eli Lilly & CO Transaction History